Quantcast
Last updated on April 18, 2014 at 15:17 EDT

Latest Navigenics Stories

2013-11-07 13:50:16

In an era of commercialized medicine, direct-to-consumer (DTC) genetic testing has been on a steady rise. Consumers can purchase a DNA sample kit, also known as a "spit kit," mail it to a testing company, and wait for an email that reveals their genetic risk for disorders like heart disease and colon cancer. However, a new Yale study reveals that members of the public, as well as physician groups, are concerned about individuals interpreting these risks without the help of a doctor....

2012-10-16 11:25:58

NASHVILLE, Tenn., Oct. 16, 2012 /PRNewswire/ -- NextGxDx, a healthcare information technology company, today announced the release of its online genetic testing platform that curates information on the more than 10,000 genetic testing products currently offered by FDA and CLIA certified labs in the U.S. According to NextGxDx's research, the database is the most comprehensive catalog of all the genetic testing products available to U.S. healthcare providers. The company also found the number...

2012-10-03 02:27:43

REDWOOD CITY, Calif., Oct. 3, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced the addition of three industry veterans to its senior leadership team. Dr. Vance Vanier joins Verinata as President, Dr. Keith Jones as Senior Vice President of Research and Development and Dr. Suchetta Bhatt as Vice President of Genetics. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) "As we expand our...

23andMe Applies For FDA Approval
2012-08-01 05:45:05

Connie K. Ho for redOrbit.com — Your Universe Online 23andMe, a company focused on personal genetics, recently took the first step in working towards Food and Drug Administration (FDA) clearance; the FDA plans to review the paperwork over the next few months. Previously, the Silicon Valley company refrained from government regulation, claiming that the service provided consumers with information rather than a medical service. CBS News reported that 23andMe submitted the first...

2012-07-30 06:25:49

MOUNTAIN VIEW, Calif., July 30, 2012 /PRNewswire/ -- 23andMe, the leading personal genetics company, today announced that it has delivered its first round of 510(k) documentation to the Food and Drug Administration (FDA). Since its 2006 inception, 23andMe largely created the direct-to-consumer market for genetic analysis. As a leader in personal genetics, the company is now the first in the industry to announce it is working towards FDA clearance. The FDA will review the filing over the...

2012-07-25 02:29:29

CARLSBAD, Calif., July 25, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. Lung cancer is currently the leading cause of cancer deaths worldwide, claiming close to 1.5 million lives every year. Early-Stage Lung Cancer Diagnostic Could Save Lives...

2012-07-16 10:25:46

CARLSBAD, Calif., July 16, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions. "Genetic analysis is becoming increasingly accessible, cost-effective and a critical part of patient clinical management," said David Agus, M.D....

2012-07-10 06:26:48

MOUNTAIN VIEW, Calif., July 10, 2012 /PRNewswire/ -- 23andMe, a leading personal genetics company, today announced its first acquisition with the purchase of CureTogether, Inc. The addition of CureTogether provides technology and talent that will improve 23andMe's ability to gather data for research while also providing customers with engaging and meaningful interactions in 23andMe's online community. Specific terms of the transaction were not disclosed. "A driving force for the acquisition...

Few Use Follow Up Services After Genetic Testing
2012-05-18 09:39:01

Connie K. Ho for RedOrbit.com Recently, genetic tests have been on the rise and are offered by more and more commercial producers. While there are many opportunities for people to participate in genetic testing, this doesn´t necessarily mean that people are following up on those services. These are the results found in a study that is published in the May 17 issue of Genetics in Medicine. The study was a collaborative project by the Multiplex Initiative, which includes researchers...

Focus Groups Share Thoughts on Direct-To-Consumer Genetic Tests
2012-05-11 06:06:14

Connie K. Ho for RedOrbit.com Researchers at Loyola University Chicago´s Stritch School of Medicine have found that patients see both benefits and risks from direct-to-consumer genetic tests. Dr. Katherine Wasson, a specialist on the ethics of direct-to-consumer genetic tests, and colleagues conducted the experiment. The study, published in the American Journal of Bioethics Primary Research, showed that the patients were concerned about the end game of the genetic test results....